St. Vincent Frontier Cancer Center-Research ( Site 0037)

Billings, Montana 59102

2 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer, Prostatic Neoplasms

Studies at this site

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) — Recruiting now
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) — Recruiting now